$6.48
-0.06[-0.92%]
At close: Apr 24
$6.48
0[0.00%]
After Hours: 6:41PM EDT
ADMA Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ADMA Biologics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/08/2024 | PM | ADMA | Q1 | -$0.03 | $0.05 | — | — | $56.91M | $77.27M | — | — | Get Alert |
02/28/2024 | PM | ADMA | Q4 | -$0.06 | $0.02 | $0.04 | 100.00% | $49.98M | $72.15M | $73.90M | 2.43% | Get Alert |
11/08/2023 | PM | ADMA | Q3 | -$0.08 | -$0.01 | $0.01 | 200.00% | $41.09M | $62.12M | $67.28M | 8.30% | Get Alert |
08/09/2023 | PM | ADMA | Q2 | -$0.07 | -$0.02 | -$0.03 | -50.00% | $33.91M | $55.50M | $60.12M | 8.33% | Get Alert |
05/10/2023 | PM | ADMA | Q1 | -$0.10 | -$0.04 | -$0.03 | 25.00% | $29.10M | $53.41M | $56.91M | 6.56% | Get Alert |
03/23/2023 | PM | ADMA | Q4 | -$0.09 | -$0.06 | -$0.06 | 0.00% | $26.38M | $45.93M | $49.98M | 8.82% | Get Alert |
11/09/2022 | PM | ADMA | Q3 | -$0.13 | -$0.08 | -$0.08 | 0.00% | $20.68M | $34.48M | $41.09M | 19.17% | Get Alert |
08/10/2022 | PM | ADMA | Q2 | -$0.14 | -$0.08 | -$0.07 | 12.50% | $17.83M | $31.81M | $33.91M | 6.59% | Get Alert |
05/11/2022 | PM | ADMA | Q1 | -$0.16 | -$0.08 | -$0.10 | -25.00% | $16.05M | $27.69M | $29.10M | 5.10% | Get Alert |
03/24/2022 | PM | ADMA | Q4 | -$0.21 | -$0.09 | -$0.09 | 0.00% | $13.96M | $21.76M | $26.38M | 21.25% | Get Alert |
11/10/2021 | PM | ADMA | Q3 | -$0.19 | -$0.14 | -$0.13 | 7.14% | $10.28M | $18.72M | $20.68M | 10.48% | Get Alert |
08/11/2021 | PM | ADMA | Q2 | -$0.23 | -$0.15 | -$0.14 | 6.67% | $7.79M | $16.42M | $17.83M | 8.59% | Get Alert |
05/12/2021 | PM | ADMA | Q1 | -$0.26 | -$0.17 | -$0.16 | 5.88% | $10.20M | $14.58M | $16.05M | 10.08% | Get Alert |
03/25/2021 | PM | ADMA | Q4 | -$0.18 | -$0.16 | -$0.21 | -31.25% | $12.04M | $12.91M | $13.96M | 8.10% | Get Alert |
11/05/2020 | PM | ADMA | Q3 | -$0.19 | -$0.19 | -$0.19 | 0.00% | $7.22M | $9.96M | $10.28M | 3.17% | Get Alert |
08/05/2020 | PM | ADMA | Q2 | -$0.25 | -$0.16 | -$0.23 | -43.75% | $6.56M | $10.57M | $7.79M | -26.32% | Get Alert |
05/06/2020 | PM | ADMA | Q1 | -$0.28 | -$0.12 | -$0.26 | -116.67% | $3.53M | $10.88M | $10.20M | -6.25% | Get Alert |
03/12/2020 | PM | ADMA | Q4 | -$0.39 | -$0.18 | -$0.18 | 0.00% | $4.06M | $10.23M | $12.04M | 17.66% | Get Alert |
11/06/2019 | PM | ADMA | Q3 | -$0.33 | — | -$0.19 | — | $4.23M | — | $7.22M | — | Get Alert |
ADMA Biologics (ADMA) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $0.04, which beat the estimate of $0.02.
The Actual Revenue was $73.9M, which beat the estimate of $72.2M.
Browse earnings estimates, EPS, and revenue on all stocks.